XML 46 R31.htm IDEA: XBRL DOCUMENT v3.5.0.2
Fair Value Measurements (Tables)
12 Months Ended
May 31, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company's financial assets and liabilities measured at fair value on a recurring basis as of May 31, 2016 and 2015, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value. Refer to Note 1 — Summary of Significant Accounting Policies for additional detail regarding the Company’s fair value measurement methodology.
 
 
As of May 31, 2016
(In millions)
 
Assets at Fair Value
 
Cash Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
774

 
$
774

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,265

 
100

 
1,165

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
831

 
827

 
4

 

U.S. Agency securities
 
679

 

 
679

 

Commercial paper and bonds
 
733

 
262

 
471

 

Money market funds
 
1,175

 
1,175

 

 

Total level 2
 
3,418

 
2,264

 
1,154

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
10

 

 

 
10

TOTAL
 
$
5,467

 
$
3,138

 
$
2,319

 
$
10

 
 
 
As of May 31, 2015
(In millions)
 
Assets at Fair Value
 
Cash Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
615

 
$
615

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
869

 
225

 
644

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
684

 
684

 

 

U.S. Agency securities
 
976

 
110

 
866

 

Commercial paper and bonds
 
914

 
352

 
562

 

Money market funds
 
1,866

 
1,866

 

 

Total level 2
 
4,440

 
3,012

 
1,428

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
8

 

 

 
8

TOTAL
 
$
5,932

 
$
3,852

 
$
2,072

 
$
8


Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of May 31, 2016 and 2015, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of May 31, 2016
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
603

 
$
487

 
$
116

 
$
145

 
$
115

 
$
30

Embedded derivatives
 
7

 
2

 
5

 
9

 
2

 
7

Interest rate swaps(2)
 
7

 
7

 

 
45

 
45

 

TOTAL
 
$
617

 
$
496

 
$
121

 
$
199

 
$
162

 
$
37

(1)
If the foreign exchange derivative instruments had been netted in the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $136 million as of May 31, 2016. As of that date, the Company had received $105 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2016.
(2)
As of May 31, 2016no amount of cash collateral had been received or posted on the derivative asset and liability balances related to the Company's interest rate swaps.
 
 
As of May 31, 2015
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
1,554

 
$
1,034

 
$
520

 
$
164

 
$
160

 
$
4

Embedded derivatives
 
7

 
2

 
5

 
11

 
2

 
9

Interest rate swaps(2)
 
78

 
78

 

 

 

 

TOTAL
 
$
1,639

 
$
1,114

 
$
525

 
$
175

 
$
162

 
$
13

(1)
If the foreign exchange derivative instruments had been netted in the Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $161 million as of May 31, 2015. As of that date, the Company had received $900 million of cash collateral and $74 million of securities from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2015.
(2)
As of May 31, 2015, the Company had received $68 million of cash collateral related to its interest rate swap
The following table presents the fair values of derivative instruments included within the Consolidated Balance Sheets as of May 31, 2016 and 2015: 
 
 
Asset Derivatives
 
Liability Derivatives
(In millions)
 
Balance Sheet
Location
 
2016
 
2015
 
Balance Sheet 
Location
 
2016
 
2015
Derivatives formally designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
$
447

 
$
825

 
Accrued liabilities
 
$
38

 
$
140

Interest rate swaps
 
Prepaid expenses and other current assets
 
7

 
78

 
Accrued liabilities
 
45

 

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
90

 
520

 
Deferred income taxes and other liabilities
 
12

 
4

Interest rate swaps
 
Deferred income taxes and other assets
 

 

 
Deferred income taxes and other liabilities
 

 

Total derivatives formally designated as hedging instruments
 
 
 
544

 
1,423

 
 
 
95

 
144

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
40

 
209

 
Accrued liabilities
 
76

 
20

Embedded derivatives
 
Prepaid expenses and other current assets
 
2

 
2

 
Accrued liabilities
 
2

 
2

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
26

 

 
Deferred income taxes and other liabilities
 
19

 

Embedded derivatives
 
Deferred income taxes and other assets
 
5

 
5

 
Deferred income taxes and other liabilities
 
7

 
9

Total derivatives not designated as hedging instruments
 
 
 
73

 
216

 
 
 
104

 
31

TOTAL DERIVATIVES
 
 
 
$
617

 
$
1,639

 
 
 
$
199

 
$
175